Rheumatoid arthritis Musculoskeletal Diseases
Conditions
Interventions
Subjects will be randomised 50:50 to receive the Rheumatoid Arthritis information booklet. Those participants who do not receive the booklet at randomisation will receive it 3 – 6 months later when th
Sponsors
Northumbria healthcare NHS foundation trust
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Subjects capable of giving informed consent in English 2. Male or female 3. Over the age of 18 years 4. Diagnosis of Rheumatoid Arthritis 5. On a stable dose of Methotrexate for at least 3 months
Exclusion criteria
Exclusion criteria: 1. Unwilling or unable to take Methotrexate 2. Unwilling or unable to return for their Methotrexate blood monitoring 3 – 6 months later 3. Unable to read the questionnaires or the Rheumatoid Arthritis booklet 4. Unable to read English
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Knowledge of RA measured using the Multiple Choice Rheumatoid Arthritis Questionnaire at the first meeting and the follow up meeting 3 – 4 months later 2. Methotrexate Adherence is measured using Visual Analogue Scales on the Methotrexate Adherence Questionnaire at the first meeting and the follow up meeting 3 – 4 months later. | — |
Secondary
| Measure | Time frame |
|---|---|
| Methotrexate levels measured from a blood sample taken from all participants at the first meeting and 3 – 4 months later at the second meeting. | — |
Countries
England, United Kingdom
Contacts
Public ContactSandra Robinson
Outcome results
None listed